# Chemotherapy With or Without Radiation, Low and Intermediate Risk Hodgkins Lymphoma, TXCH-HD-12A

> **NCT01858922** · PHASE2 · COMPLETED · sponsor: **Baylor College of Medicine** · enrollment: 40 (actual)

## Conditions studied

- Hodgkin Disease

## Interventions

- **DRUG:** ABVE-PC
- **DRUG:** DECA

## Key facts

- **NCT ID:** NCT01858922
- **Lead sponsor:** Baylor College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12-19
- **Primary completion:** 2019-08-12
- **Final completion:** 2019-08-12
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2024-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01858922

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01858922, "Chemotherapy With or Without Radiation, Low and Intermediate Risk Hodgkins Lymphoma, TXCH-HD-12A". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01858922. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*